Dodson Vicki L 4
4 · NATIONAL HEALTHCARE CORP · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
NHC Vicki L Dodson (Sr. VP) Receives Restricted Shares
What Happened
Vicki L. Dodson, Senior Vice President of Patient Services at National Healthcare Corp (NHC), received an award of 1,082 restricted common shares on 2026-02-27. The shares were granted at $0.00 (no cash paid), so the reported transaction value is $0; the award is compensatory rather than an open‑market purchase or sale.
Key Details
- Transaction date: 2026-02-27 (Grant / Code A)
- Shares granted: 1,082; Price: $0.00; Reported value: $0
- Filing date: 2026-03-03 — filed within the typical two business‑day Form 4 deadline for a 2026-02-27 transaction (timely)
- Shares owned after transaction: not reported in the filing
- Footnote: Restricted shares vest in three equal installments — 33 1/3% on 2027-01-01, 33 1/3% on 2028-01-01, and the final 33 1/3% on 2029-01-01
- No 10b5-1 plan, tax‑withholding sale, or immediate disposition noted in the filing
Context
Restricted stock awards are a form of compensation that vest over time; they do not involve an immediate cash purchase or sale and typically cannot be sold until vested. Such grants are common for executive and senior management pay and should be viewed as compensation rather than a direct insider market signal.
Insider Transaction Report
- Award
Shares of Common Stock held in my name
[F1]2026-02-27+1,082→ 11,371.546 total
- 3,734
Option to Purchase Common Stock
Exercise: $53.94From: 2024-03-08Exp: 2028-03-08→ Common Stock (3,734 underlying) - 8,000
Option to Purchase Common Stock
Exercise: $94.10From: 2025-03-05Exp: 2029-03-05→ Common Stock (8,000 underlying) - 13,500
Option to Purchase Common Stock
Exercise: $90.62From: 2026-02-24Exp: 2030-02-24→ Common Stock (13,500 underlying) - 14,000
Option to Purchase Common Stock
Exercise: $157.13From: 2027-02-23Exp: 2031-02-23→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.